WADA The 2012 Monitoring Program

1 Jan 2012

THE 2012 MONITORING PROGRAM*

The following substances are placed on the 2012 Monitoring Program:

1. Stimulants:

In-Competition Only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (< 150 micrograms per milliliter), synephrine.

2. Narcotics: In-Competition Only: Hydrocodone, morphine/codeine ratio; tramadol.

3. Glucocorticosteroids: Out-of-Competition Only

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”

WADA The 2011 Monitoring Program

1 Jan 2011

THE 2011 MONITORING PROGRAM*

The following substances are placed on the 2011 Monitoring Program:

1. Stimulants:

In-Competition Only: Bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (< 150 micrograms
per milliliter), synephrine.

2. Narcotics:

In-Competition Only: Morphine/codeine ratio.

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”

WADA 2014 Prohibited List Summary of Major Modifications and Explanatory Notes

11 Sep 2013

2014 Prohibited List
Summary of Major Modifications and Explanatory Notes

PROHIBITED SUBSTANCES
Use of International Non-proprietary Names (INN)
With the assistance of the World Health Organisation, the nomenclature of some substances on the List has been updated to International Non-proprietary Names (INN). For ease of the reviewer the previous name has been included and no substance has been deleted.
S1. Anabolic Agents
• Changes were made to the definitions of “exogenous” and “endogenous” for purposes of clarification and accuracy.
S2. Peptide Hormones, Growth Factors and Related Substances
• Releasing factors are prohibited and that is made clear in points S2.2, S2.3 and S2.4. In addition other prohibited growth factors are listed separately.
S5. Diuretics and other Masking Agents
• Vasopressin V2 antagonists (vaptans) were added as an example of a diuretic subclass.
M1. Manipulation of Blood and Blood Components
• For the purpose of scientific accuracy, the term allogenic was introduced.
SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION
S6. Stimulants:
• Some drugs that metabolize to amfetamine or methamfetamine have been reclassified because improved analytical techniques permit the identification of the administered drug and corresponding metabolites; MDMA and MDA are reclassified because they are now recognized as less likely to be used as doping agents; cathinone and its analogues (e.g. mephedrone, methedrone, α- pyrrolidinovalerophenone) and trimetazidine have been added as examples to reflect emerging patterns of drug use.
SUBSTANCES PROHIBITED IN PARTICULAR SPORTS
P1. Alcohol
• Changes were made to the wording describing the blood alcohol threshold, in the interest of accuracy.
• “Aeronautic” has been replaced by “Air Sports” and “FITA” has been replaced by its new acronym “WA” (World Archery).
P2. Beta-blockers
• “FITA” has been replaced by its new acronym “WA” (World Archery)
MONITORING PROGRAM
• In order to detect potential patterns of abuse, mitragynine has been added to the Narcotics class of the Monitoring Program

FILA 2010 WADA vs FILA & Anvar Gazimagomedov

24 Nov 2010

On 14 October 2010 the FILA Sport Judge decided to give a reprimand to the Russian Athlete Anvar Gazimagomedov after his sample tested positive for the prohibited substance atenolol.
Hereafter WADA appealed the FILA Sport Judge decision of 14 October 2010 with the FILA Appeal Commission.

The Athlete claimed that there were several departures from the sample collection procedure and that the prohibited substance came into his body during his visit at the dentist or with the medication he used for his headache.

The Appeal Commission concludes that the Athlete produced no evidence in support of his allegations about the sample collection and his statement about how the prohibited substance came into his body.
Therefore the FILA Appeal Commission decides to set aside the FILA Sport Judge decision of 14 October 2010 and to impose a 2 year period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 29 June 2010.

AFLD 2011 FFC vs Respondent M19

17 Feb 2011

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M19 for a violation of the Anti-Doping Rules. During a cycling event on June 19, 2010, a sample was taken for doping test purposes. The sample tested positive on pseudoephedrine. Pseudoephedrine is a prohibited substances according the World Anti-Doping Agency prohibited list and is regarded as a specified substance.

History
The respondent explained that the positive test was caused by medication used to treat a constant nasal obstruction.

Decision
1. The sanction is a period of ineligibility of six months in which the athlete can't take part in competition or manifestions of the FFC, equal to the decision dated October 28, 2010 of the appeal committee of the FFC only extended to all French sport federations.
2. All his results obtained at June 19, 2010, are cancelled. Medals, points and prizes are withdrawn.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

WADA International Standard for the Protection of Privacy and Personal Information (ISPPPI) 2009 (2.0)

11 May 2009

International Standard for the Protection of Privacy and Personal Information : the World Anti-Doping Code / World Anti-Doping Agency (WADA). - Montreal : WADA, 2008. - (International Standard for the Protection of Privacy and Personal Information (ISPPPI) version 2.0, in effect on 1 June 2009)


The International Standard for the Protection of Privacy and Personal Information was first adopted and approved by the World Anti-Doping Agency Executive Committee on 9 May 2009. The enclosed represents version 2.0 which becomes effective as of 1 June 2009.

The purpose of the International Standard for the Protection of Privacy and Personal Information is to ensure that Anti-Doping Organizations apply appropriate, sufficient and effective privacy protections to the Personal Information they Process when conducting anti-doping programs, in recognition of the fact that Personal Information gathered in the anti-doping context can impinge upon and implicate the privacy rights and interests of persons involved in and associated with organized sport.

The Code, in particular, requires Athletes and Athlete Support Personnel to furnish a significant amount of Personal Information to Anti-Doping Organizations. As a result, it is essential that Anti-Doping Organizations appropriately protect the Personal Information that they collect both to meet legal standards and to ensure the continued confidence and trust of those who participate in organized sport.

The Code recognizes and affirms the importance of ensuring that the privacy interests of persons participating in anti-doping programs based on the Code are fully respected. In support of this commitment, this International Standard provides mandatory rules and standards relating to the protection of Personal Information by Anti-Doping Organizations.

WADA International Standard for Therapeutic Use Exemptions (ISTUE) 2011

1 Oct 2010

Therapeutic Use Exemptions : the World Anti-Doping Code International Standard / World Anti-Doping Agency (WADA). - Montreal : WADA, 2010. - (International Standard for Therapeutic Use Exemptions (ISTUE) version 5.0, effective on 1 January 2011)


The International Standard for Therapeutic Use Exemptions was first adopted in 2004 and became effective in 2005. The enclosed represents version 5.0 that incorporates revisions to the International Standard for Therapeutic Use Exemptions that were approved by the World Anti-Doping Agency Executive Committee on 18 September 2010. The revised International Standard for Therapeutic Use Exemptions is effective as of 1 January 2011.

The purpose of the International Standard for Therapeutic Use Exemptions is to ensure that the process of granting therapeutic use exemptions is harmonized across sports and countries.

The Code permits Athletes to apply for therapeutic use exemptions (TUE) i.e. permission to use, for therapeutic purposes, substances or methods contained in the List of Prohibited Substances or Methods where Use would otherwise be prohibited.

The International Standard for TUE includes criteria for granting a TUE, confidentiality of information, the formation of Therapeutic Use Exemptions Committees and the TUE application process.

This Standard applies to all Athletes as defined by and subject to the Code i.e. able-bodied Athletes and Athletes with disabilities.

AFLD 2011 FFA vs Respondent M15

17 Feb 2011

Facts
The French Athletics Federation (Fédération Française d'Athlétisme, FFA) charges respondent M15 for a violation of the Anti-Doping Rules. During an athletics event on September 25, 2010, a sample was taken for doping test purposes. The analysis of the sample showed the presence of prednisone and prednisolone. Prednisone and prednisolone are prohibited substance according the World Anti-Doping Agency (WADA) prohibited list, they are regarded as specified substances.

History
The respondent used medication against angina which caused the positive test.

Decision.
1. The sanction is a period of ineligibility of six months in which respondent can't take part in competition or manifestations organized or authorized by the FFA.
2. All the results obtained on September 25, 2010, are cancelled. Medals, points and prizes are withdrawn.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

AFLD 2011 FFHMFAC vs Respondent M14

17 Feb 2011

Facts
The French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (Fédération Française d'Halterophilie, Musculation, Force Athlétique et Culturisme, FFHMFAC) charges respondent M14 for a violation of the Anti-Doping Rules. During a weightlifting event on April 17, 2010, a sample was taken for doping test purposes. The analysis of the sample showed the presence of furosemide, a metabolite of nandrolone, 3α-hydroxy-5α-androstan-17-one, a metabolite of mesterolone, testosterone on epitestosterone in an abnormal high level (spectro analysis shows exogenous metabolites of testosterone) and metabolites of stanozolol . These substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent declared that the positive test derived from supplements he used, ordered by internet, he had used these, during training, from the end of November 2009 till the date of the doping test.

Decision
1. The sanction is a period of ineligibility of four years in which respondent can't take part in competition or manifestations organized or authorized by the FFHMFAC which was pronounced by the decision of the disciplinary committee of the FFHMFAC on August 3, 2010, and now extended to the other French sport federations.
2. The decision starts on the date of notification.
5. The decision will be published and sent to the parties involved.

WADA The 2010 Monitoring Program

1 Jan 2010

THE 2010 MONITORING PROGRAM*

The following substances are placed on the 2010 Monitoring Program:

1. Stimulants:

In-Competition Only: Bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (< 150 micrograms per milliliter), synephrine.

2. Narcotics:

In-Competition Only: Morphine/codeine ratio.

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin